
CFR
USDCullen/Frost Bankers Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$126.820
Kõrge
$126.510
Madal
$125.590
Maht
0.28M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
8.1B
Tööstusharu
Banks - Regional
Riik
United States
Kauplemisstatistika
Keskmine maht
0.47M
Börs
NYQ
Valuuta
USD
52 nädala vahemik
Tehisintellekti analüüsiaruanne
Viimati uuendatud: 22. mai 2025CFR (Cullen/Frost Bankers Inc. Common Stock): Analyzing Recent Moves & What Might Come Next
Stock Symbol: CFR Generate Date: 2025-05-22 15:37:19
Let's break down what's been happening with Cullen/Frost Bankers stock and what the recent information might suggest.
Recent News Buzz
What's the word on the street for CFR? Looking at the latest analyst notes from early May, it's a bit of a mixed picture, but with a slight positive tilt on price targets.
- Two different firms, Stephens & Co. and Barclays, both kept their "Equal-Weight" rating on the stock. Think of "Equal-Weight" as basically saying, "Hold onto it, it should perform roughly in line with similar stocks." The interesting part is both of these firms actually raised their price targets – Stephens went from $138 to $141, and Barclays bumped theirs from $130 to $135. That suggests they see a little more room for the stock price to climb than they did before.
- On the flip side, RBC Capital maintained their "Sector Perform" rating (another way of saying "Hold") but lowered their price target slightly, from $147 to $140.
So, the overall vibe from these analysts is neutral on the rating front, but two out of three are nudging their price expectations higher, even if one pulled back a bit from a higher number. It's not a ringing endorsement to buy aggressively, but it's not a warning sign to sell everything either.
Checking the Price Action
Now, let's look at what the stock price itself has been doing over the past few months. It's been quite a ride! Back in late February, the stock was trading up around $140. Then, it took a pretty significant tumble through March and into early April, hitting lows down around $100-$105.
Since that April dip, though, CFR has been on a noticeable recovery path. It's been steadily climbing back up, moving from the low $100s into the $120s and recently touching the $130 mark briefly in mid-May before pulling back slightly.
As of today, May 22nd, the stock closed around $127.05. This puts it firmly in the upper half of that recovery range we've seen since April, but still well below where it was at the start of the year.
What about the very near future? An AI prediction model suggests a bit of volatility right around the corner. It's forecasting a dip of over 2% today (which seems to have happened based on the closing price vs. open), a small bounce tomorrow, and then another dip the day after. This short-term forecast points to some potential downward pressure.
Putting It All Together: Outlook & Ideas
So, what does this picture suggest for CFR right now?
We've got analysts who are mostly neutral on the stock but see price targets generally above the current level. We've seen the stock recover nicely from a significant drop. But, the AI is flagging potential short-term weakness.
Based on this mix, the apparent near-term leaning seems to be one of caution or 'hold' if you're already in, or 'wait and see' if you're thinking about buying. The strong recovery has been positive, but the AI's prediction of a dip suggests the recent upward momentum might pause or reverse briefly.
- Potential Entry Consideration: If you're interested in getting into CFR, waiting for that predicted dip could be a strategy. The historical data shows the stock found support around the $120-$125 area during its recent climb. If the AI's forecast plays out, a dip back towards that range, perhaps around $125 or slightly lower, might be a potential area to consider, as it aligns with recent support levels seen during the recovery. This isn't a guarantee, just a level that looks interesting based on the chart.
- Potential Exit/Stop-Loss Consideration: Managing risk is always important. The AI recommendation data offers some potential levels to think about. It flags $129.13 as a potential take-profit level – this is right around the recent highs the stock touched. For cutting losses, a potential stop-loss level is suggested around $120.89. This level sits below the recent recovery range and could be a point to consider exiting if the stock price falls significantly, helping limit potential losses.
Company Context
Remember, Cullen/Frost Bankers is a regional bank operating primarily in Texas. They serve a wide range of industries there. This means the health of the Texas economy and the specific sectors they lend to (like energy, construction, etc.) can have a big impact on their business and, in turn, their stock price. The recent price recovery could be tied to improving sentiment around regional banks or the Texas economy, but any negative news on those fronts could quickly change the picture.
Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.
Seotud uudised
RBC Capital Maintains Sector Perform on Cullen/Frost Bankers, Lowers Price Target to $140
RBC Capital analyst Karl Shepard maintains Cullen/Frost Bankers with a Sector Perform and lowers the price target from $147 to $140.
Stephens & Co. Maintains Equal-Weight on Cullen/Frost Bankers, Raises Price Target to $141
Stephens & Co. analyst Matt Olney maintains Cullen/Frost Bankers with a Equal-Weight and raises the price target from $138 to $141.
Barclays Maintains Equal-Weight on Cullen/Frost Bankers, Raises Price Target to $135
Barclays analyst Jared Shaw maintains Cullen/Frost Bankers with a Equal-Weight and raises the price target from $130 to $135.
Tehisintellekti ennustusBeta
Tehisintellekti soovitus
Uuendatud kell: 12. juuni 2025, 13:59
61.8% Kindlus
Risk ja kauplemine
Sisenemispunkt
$127.53
Võta kasum
$130.35
Peata kahjum
$122.97
Põhitegurid
Seotud aktsiad

JNJ
Johnson & Johnson

SPT
Sprout Social Inc

PRGS
Progress Software Corporation (DE)

USNA
USANA Health Sciences Inc.

AFGE
American Financial Group Inc. 4.500% Subordinated Debentures due 2060
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.